But unless you’re of your rocker from too much Fosters, don’t get your hopes up too high yet.
Nevertheless, in this world plagued by big Pharma epidemics, like the ongoing opioids crisis and the since years already identified — but ever-continuing — antibiotics resilience, Australian scientists discovered that CBD could possibly be used as an alternative to antibiotics in specific cases.
During a test on the bacteria of the Gram-positive class — more specifically staphylococcus aureus and streptococcus pneumoniae, respectively responsible for the MRSA bug and pneumonia — they discovered that not only did cannabidiol kill all strains of the bacteria but the bacteria didn’t develop any resilience against the treatment either. The scientists tested exposure to the drug for more than 20 days, the usual period the most resilient bugs can survive antibiotic treatment, and no resistance to the treatment with CBD was developed.
Additionally, the scientists also tested CBD on mice with a skin condition and the results were positive again.
Most interestingly about the results, or at least the study’s team’s honesty is that they admitted that the specifics of the workings aren’t yet known to them and thus CBD — and its medical prospects — need further study.
“We still don't know how it works, and it may have a unique mechanism of action given it works against bacteria that have become resistant to other antibiotics, but we still don't know how."
"So far, we have only shown it works topically, on the skin surface. To be really useful, it would be good if we could show that it treated systemic infections e.g. pneumonia, or complicated tissue infections, where you have to give it orally or by intravenous dosing. A very preliminary study didn't show that it works in these more difficult models."
— Mark Blaskovich, Study Leader and Senior Research Chemist at Centre for Superbug Solutions
Most interesting about this development is that it was the first time that CBD was considered as an alternative to the widespread, and by many doctors used as “miracle solution”, antibiotics.
The study was done using synthetic cannabinoids, according to Blaskovich, but despite the use of synthetic material the Centre did struggle obtaining the required permits from the state.
Blaskovich also emphasized to Newsweek that people shouldn’t ditch their antibiotics yet as all results were obtained in lab conditions, and with test tubes, rather than based on actual analysis on humans.
The study was not published for peer-review, but presented at the Annual Conference of the American Society for Microbiology, ASM 2019 in SF, California. Molecular Biology Lecturer Dr. Andrew Edwards, Imperial College London, joined the positive vibes from the study and emphasized that cannabidiols have yet to become appreciated for their antibacterial capacities when treating Gram-positive bacteria caused infections. He even could imagine the substance becoming fast-tracked in clinics if CBD is proven to be efficient.
Together with previously discovered health capabilities of THC and CBD, this study may be one of the most positive — and exciting — discoveries in the medical use field yet as it is estimated that every year up to 1 million of people die from the globally increasing epidemic. In the US alone, more than 2 million people have suffered infections with resilient bacteria.
Yet, as ever, we urgently need more research and, of course, the governments to get their act together and start issuing licenses to universities and academics in order to properly research the properties of cannabis and its components.
Yet, it seems inevitable that some day — hopefully sooner than later — many chemical drugs which may or may not yet have run their course, will be replaced with cannabis derived, or based, solutions.